figshare
Browse
12885_2015_1630_MOESM1_ESM.pptx (84.25 kB)

Additional file 1: of Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

Download (84.25 kB)
presentation
posted on 2015-09-09, 05:00 authored by Yoshito Komatsu, Chikashi Ishioka, Ken Shimada, Yasuhide Yamada, Makio Gamoh, Atsushi Sato, Tatsuro Yamaguchi, Satoshi Yuki, Satoshi Morita, Shin Takahashi, Rei Goto, Minoru Kurihara
Table S1. Ethic committee. (PPTX 81 kb)

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    Additionalrandomized phase III studyPPTX 81 kboxaliplatin-based chemotherapybevacizumabcombination chemotherapymetastatic colorectal cancer Table S 1. Ethic committeeStudy protocolfirst-line therapyTRICOLORE trialirinotecan

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC